Brian Baloun is an associate in the Chicago office of Latham & Watkins. Mr. Baloun advises global clients, including public and privately held companies, as well as private equity sponsors, family offices, and their portfolio companies, on complex global and domestic M&A transactions.
Profile
Experience
Mr. Baloun’s representative experience includes advising:
Public Company M&A
- Imago BioSciences, Inc., a clinical stage biopharmaceutical company developing new medicines for the treatment of bone marrow diseases, in its pending US$1.35 billion take-private sale to Merck & Co., Inc.
- Flame Acquisition Corp., a special purpose acquisition entity focused on the energy industry in North America, in its business combination with Sable Offshore Corp.
- ironSource Ltd., a leading business platform that empowers mobile content creators to turn their apps into scalable businesses, in its US$4.4 billion merger with Unity Software, Inc.
- Cerner Corporation, a leading provider of digital information services used within hospitals and health systems, in its US$28 billion take-private sale to Oracle
- Silicon Motion Technology Corporation, a global leader in designing and marketing NAND flash controllers for solid state storage devices, in its pending US$3.8 billion take-private sale to MaxLinear, Inc.
Private Company M&A
- Crown Paper Group, an integrated mill and containerboard operation with a strategic presence in the growing markets of the Pacific Northwest and Western Canada, in its sale to Atlas Holdings.
Private Equity / Family Office M&A
- BDT Capital in several acquisitions, joint ventures, and strategic partnerships
- A private equity sponsor in connection with an acquisition in the utility industry
- GTCR in its acquisition of Katena Products, Inc., a medical device company focused on ophthalmic surgery products
Qualifications
Bar Qualification
- Illinois
Education
- JD, Loyola University Chicago School of Law, 2020
Magna Cum Laude - B.A. in Political Science, University of Iowa, 2016
Practices
News & Insights
November 21, 2022
Our Work
Multidisciplinary team advises the clinical stage biopharmaceutical company developing new medicines for the treatment of bone marrow diseases.
November 2, 2022
Our Work
Latham & Watkins Advises Flame Acquisition Corp. in Its Business Combination With Sable Offshore Corp.
Firm advises the special purpose acquisition entity focused on the North American energy industry in the transaction.
October 13, 2022
Our Work
July 14, 2022
Our Work